Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 101 - 127 av 127 resultater
Tid
Selskap
Tittel
Sektor
Kategori
09 Dec 2021
07:30 CET
THERAVET
TheraVet: Commercial Launch of BIOCERA-VET® for Canine Osteosarcoma in Belgium, France and The Netherlands
20103015 Pharmaceuticals
Other subject
09 Dec 2021
07:30 CET
THERAVET
TheraVet : Lancement commercial de BIOCERA-VET® pour l’ostéosarcome canin en Belgique, en France et aux Pays-Bas
20103015 Pharmaceuticals
Other subject
22 Nov 2021
17:45 CET
THERAVET
TheraVet Broadens Significantly its BIOCERA-VET® Product Line Through Major Distribution and Research Agreements
20103015 Pharmaceuticals
Other subject
22 Nov 2021
17:45 CET
THERAVET
TheraVet élargit significativement sa gamme BIOCERA-VET® grâce à d’importants accords de distribution et de recherche
20103015 Pharmaceuticals
Other subject
15 Nov 2021
07:30 CET
THERAVET
TheraVet Announces Positive Safety and Efficacy Results for BIOCERA-VET® in Canine Osteosarcoma
20103015 Pharmaceuticals
Other subject
15 Nov 2021
07:30 CET
THERAVET
TheraVet annonce des résultats de sécurité et d’efficacité positifs pour BIOCERA-VET® dans l’ostéosarcome du chien
20103015 Pharmaceuticals
Other subject
09 Nov 2021
07:30 CET
THERAVET
TheraVet Announces the Signing of a Research Contract With Degroof Petercam
20103015 Pharmaceuticals
Other subject
09 Nov 2021
07:30 CET
THERAVET
TheraVet annonce la signature d’un contrat de recherche avec Degroof Petercam
20103015 Pharmaceuticals
Other subject
03 Nov 2021
07:30 CET
THERAVET
TheraVet élargit sa gamme de substituts osseux
20103015 Pharmaceuticals
Other subject
03 Nov 2021
07:30 CET
THERAVET
TheraVet Expands Its Bone Substitutes Product Line
20103015 Pharmaceuticals
Other subject
29 Oct 2021
19:00 CEST
THERAVET
TheraVet : Mise à disposition du rapport semestriel 2021
20103015 Pharmaceuticals
Other subject
26 Oct 2021
17:45 CEST
THERAVET
TheraVet : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la loi du 02 mai 2007)
20103015 Pharmaceuticals
Other subject
26 Oct 2021
07:30 CEST
THERAVET
TheraVet : Premiers patients traités avec le substitut osseux BIOCERA-VET® aux États-Unis
20103015 Pharmaceuticals
Other subject
26 Oct 2021
07:30 CEST
THERAVET
TheraVet: First Patients Treated With BIOCERA-VET® Bone Surgery in the United States of America
20103015 Pharmaceuticals
Other subject
21 Oct 2021
07:30 CEST
THERAVET
TheraVet : Lancement commercial de BIOCERA-VET® en France et aux Pays-Bas
20103015 Pharmaceuticals
Other subject
21 Oct 2021
07:30 CEST
THERAVET
TheraVet: Commercial launch of BIOCERA-VET® in France and The Netherlands
20103015 Pharmaceuticals
Other subject
07 Oct 2021
17:45 CEST
THERAVET
TheraVet apporte des précisions sur ses relations avec la société Graftys
20103015 Pharmaceuticals
Other subject
22 Sep 2021
17:45 CEST
THERAVET
TheraVet Announces Its 2021 Half-year Results and Provides an Update on the Development of Its Activities
20103015 Pharmaceuticals
Other subject
22 Sep 2021
17:45 CEST
THERAVET
TheraVet annonce ses résultats financiers du 1er semestre 2021 et fait le point sur le développement de ses activités
20103015 Pharmaceuticals
Other subject
10 Sep 2021
07:30 CEST
THERAVET
TheraVet annonce le lancement de l’étude clinique pivot multicentrique européenne évaluant VISCO-VET dans l’arthrose canine
20103015 Pharmaceuticals
Other subject
10 Sep 2021
07:30 CEST
THERAVET
TheraVet Announces the Launch of the Pivotal European Multicentric Clinical Study of VISCO-VET in Canine Osteoarthritis
20103015 Pharmaceuticals
Other subject
08 Sep 2021
07:30 CEST
THERAVET
TheraVet annonce des résultats de sécurité et d’efficacité positifs pour VISCO-VET dans l’arthrose canine
20103015 Pharmaceuticals
Other subject
08 Sep 2021
07:30 CEST
THERAVET
TheraVet Announces Positive Safety and Efficacy Results for VISCO-VET in Canine Osteoarthritis
20103015 Pharmaceuticals
Other subject
01 Sep 2021
07:30 CEST
THERAVET
TheraVet Announces the Appointment of Veerle Zonnekeyn as Director of Regulatory Affairs
20103015 Pharmaceuticals
Other subject
01 Sep 2021
07:30 CEST
THERAVET
TheraVet annonce la nomination de Veerle Zonnekeyn comme Directrice des Affaires Réglementaires
20103015 Pharmaceuticals
Other subject
09 Aug 2021
17:45 CEST
THERAVET
TheraVet S.A.: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
20103015 Pharmaceuticals
Other subject
09 Aug 2021
17:45 CEST
THERAVET
TheraVet : Information relative au nombre total de droits de vote et d’actions composant le capital social
20103015 Pharmaceuticals
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
3
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva